Literature DB >> 11564527

Long-term intrathecal catheterization in the rat.

L Jasmin1, P T Ohara.   

Abstract

We report an intrathecal (i.t.) catheter system that permits repeated administration of volumes of 10 microl or more in the awake rat over many months. A small skin incision is made and a 32 ga polyurethane catheter is inserted in the sacral subarachnoid space using a modified 22 ga needle. The other end of the catheter is tunneled subcutaneously to the flank and exteriorized through a titanium port. The device is well tolerated, does not cause sensory or motor deficits, and does not interfere with behavioral testing. Rats equipped with this device can be housed with other rats. Over the 9 month observation period the function of the catheter was verified by repeated injection of 15 microl of 2% lidocaine that caused temporary paraplegia. Out of 12 implanted rats, the number of fully functional catheters was 10 at 3 months, seven at 6 months, and six at 9 months. At 3 months, i.t. injection of anti-dopamine-beta-hydroxylase antibodies conjugated to saporin (DBH-SAP, 5 microg/10 microl) resulted in noradrenergic denervation of the spinal cord in all rats (n=10). We propose that intrathecal catheterization is well suited for long term behavioral and pharmacological studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564527     DOI: 10.1016/s0165-0270(01)00420-4

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  8 in total

1.  Knockdown of L calcium channel subtypes: differential effects in neuropathic pain.

Authors:  Pascal Fossat; Eric Dobremez; Rabia Bouali-Benazzouz; Alexandre Favereaux; Sandrine S Bertrand; Kalle Kilk; Claire Léger; Jean-René Cazalets; Ulo Langel; Marc Landry; Frédéric Nagy
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

2.  Treatment of rat spinal cord injury with the neurotrophic factor albumin-oleic acid: translational application for paralysis, spasticity and pain.

Authors:  Gerardo Avila-Martin; Iriana Galan-Arriero; Julio Gómez-Soriano; Julian Taylor
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

3.  Substance P-driven feed-forward inhibitory activity in the mammalian spinal cord.

Authors:  Terumasa Nakatsuka; Meng Chen; Daisuke Takeda; Christopher King; Jennifer Ling; Hong Xing; Toyofumi Ataka; Charles Vierck; Robert Yezierski; Jianguo G Gu
Journal:  Mol Pain       Date:  2005-06-29       Impact factor: 3.395

4.  miR-365 targets β-arrestin 2 to reverse morphine tolerance in rats.

Authors:  Jian Wang; Wei Xu; Tao Zhong; Zongbin Song; Yu Zou; Zhuofeng Ding; Qulian Guo; Xinzhong Dong; Wangyuan Zou
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

5.  Peripheral Nerve Injury-Induced Astrocyte Activation in Spinal Ventral Horn Contributes to Nerve Regeneration.

Authors:  Changhui Qian; Dandan Tan; Xianghai Wang; Lixia Li; Jinkun Wen; Mengjie Pan; Yuanyuan Li; Wutian Wu; Jiasong Guo
Journal:  Neural Plast       Date:  2018-04-03       Impact factor: 3.599

6.  Treatment with albumin-hydroxyoleic acid complex restores sensorimotor function in rats with spinal cord injury: Efficacy and gene expression regulation.

Authors:  Gerardo Avila-Martin; Manuel Mata-Roig; Iriana Galán-Arriero; Julian S Taylor; Xavier Busquets; Pablo V Escribá
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

7.  CD4+ αβ T cell infiltration into the leptomeninges of lumbar dorsal roots contributes to the transition from acute to chronic mechanical allodynia after adult rat tibial nerve injuries.

Authors:  Bin Du; You-Quan Ding; Xia Xiao; Hong-Yi Ren; Bing-Yin Su; Jian-Guo Qi
Journal:  J Neuroinflammation       Date:  2018-03-15       Impact factor: 8.322

8.  Upregulation of Mlxipl induced by cJun in the spinal dorsal horn after peripheral nerve injury counteracts mechanical allodynia by inhibiting neuroinflammation.

Authors:  Hongrui Zhan; Yaping Wang; Shi Yu; Guiyuan Cai; Yanyan Zeng; Junqin Ma; Wei Liu; Wen Wu
Journal:  Aging (Albany NY)       Date:  2020-06-09       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.